1. Home
  2. PHAR vs HTBI Comparison

PHAR vs HTBI Comparison

Compare PHAR & HTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • HTBI
  • Stock Information
  • Founded
  • PHAR 1988
  • HTBI 1926
  • Country
  • PHAR Netherlands
  • HTBI United States
  • Employees
  • PHAR N/A
  • HTBI N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • HTBI Savings Institutions
  • Sector
  • PHAR Health Care
  • HTBI Finance
  • Exchange
  • PHAR Nasdaq
  • HTBI Nasdaq
  • Market Cap
  • PHAR 679.0M
  • HTBI 641.9M
  • IPO Year
  • PHAR N/A
  • HTBI 2012
  • Fundamental
  • Price
  • PHAR $9.55
  • HTBI $35.02
  • Analyst Decision
  • PHAR Strong Buy
  • HTBI Buy
  • Analyst Count
  • PHAR 3
  • HTBI 4
  • Target Price
  • PHAR $27.00
  • HTBI $39.00
  • AVG Volume (30 Days)
  • PHAR 5.4K
  • HTBI 31.9K
  • Earning Date
  • PHAR 03-13-2025
  • HTBI 01-31-2025
  • Dividend Yield
  • PHAR N/A
  • HTBI 1.37%
  • EPS Growth
  • PHAR N/A
  • HTBI 14.18
  • EPS
  • PHAR N/A
  • HTBI 3.52
  • Revenue
  • PHAR $285,745,000.00
  • HTBI $187,440,000.00
  • Revenue This Year
  • PHAR $20.08
  • HTBI N/A
  • Revenue Next Year
  • PHAR $9.22
  • HTBI N/A
  • P/E Ratio
  • PHAR N/A
  • HTBI $9.73
  • Revenue Growth
  • PHAR 30.64
  • HTBI 2.84
  • 52 Week Low
  • PHAR $6.65
  • HTBI $23.55
  • 52 Week High
  • PHAR $13.20
  • HTBI $38.99
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 50.97
  • HTBI 56.87
  • Support Level
  • PHAR $9.37
  • HTBI $31.11
  • Resistance Level
  • PHAR $10.01
  • HTBI $33.83
  • Average True Range (ATR)
  • PHAR 0.52
  • HTBI 0.84
  • MACD
  • PHAR -0.10
  • HTBI 0.27
  • Stochastic Oscillator
  • PHAR 28.08
  • HTBI 96.90

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About HTBI HomeTrust Bancshares Inc.

HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products.

Share on Social Networks: